Pfizer shares tumbled more than 7 per cent after the US drugmaker forecast 2024 revenues that were below consensus estimates, as the company attempts to chart a future for growth without blockbuster Covid-19 products.
辉瑞(Pfizer)股价下跌逾7%，此前这家美国制药商预计的2024年营收低于市场共识预期。该公司正试图摸索出在没有重磅新冠(Covid-19)产品的情况下实现未来增长的道路。
您已阅读12%（305字），剩余88%（2314字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。